Valuation BioCryst Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-18 EDT			5-day change	1st Jan Change
8.990 ^USD	+0.45%		+3.33%	+15.26%

06-12	BioCryst Pharmaceuticals' New Clinical Data Demonstrated Reduced Hereditary Angioedema Attacks With Orladeyo Treatment	MT
06-12	BioCryst Pharmaceuticals Presents New Clinical Data and Real-World Evidence for HAE Portfolio at the European Academy of Allergy and Clinical Immunology Annual Meeting	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,492	2,140	1,227	1,558	1,642	2,285	-	-
Change	-	-14.12%	-42.68%	26.97%	5.43%	39.13%	-	-
Enterprise Value (EV)	2,124	2,140	1,654	2,065	1,642	2,285	2,285	2,285
Change	-	0.77%	-22.74%	24.91%	-20.49%	39.13%	0%	0%
P/E	-13.4x	-8.63x	-5.08x	-17.5x	6.45x	-3.75x	30.9x	21x
PBR	-23.9x	-7.32x	-2.71x	-3.27x	-	-	-	-
PEG	-	-0.3x	0.5x	0.3x	-0x	0x	-0x	0.4x
Capitalization / Revenue	15.9x	7.9x	3.7x	3.46x	1.88x	3.41x	3.14x	2.57x
EV / Revenue	0x	0x	0x	0x	0x	3.41x	3.14x	2.57x
EV / EBITDA	-0x	-0x	-0x	-0x	0x	-3.64x	26.7x	-
EV / EBIT	-0x	-0x	-0x	-0x	0x	-3.67x	24x	13.1x
EV / FCF	-0x	-0x	-0x	-0x	0x	-17x	12.5x	7.95x
FCF Yield	-5.8%	-7.63%	-7.93%	-3.41%	21%	-5.89%	8%	12.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.03	-1.33	-1.18	-0.43	1.21	-2.395	0.2912	0.4283
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	157.2	270.8	331.4	450.7	874.8	671	727.2	889.5
EBITDA ¹	-176.9	-147	-102.1	-1.297	342.4	-627.8	85.62	-
EBIT ¹	-177.7	-148.4	-103.7	-2.543	341	-622.7	95.07	173.9
Net income ¹	-184.1	-247.1	-226.5	-88.88	263.9	-673.9	41.89	93.89
Net Debt	-368.3	-	426.7	507.7	-	-	-	-
Reference price ²	13.850	11.480	5.990	7.520	7.800	8.990	8.990	8.990
Nbr of stocks (in thousands)	179,936	186,424	204,809	207,133	210,543	254,163	-	-
Announcement Date	2/23/22	2/21/23	2/26/24	2/24/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOCRYST PHARMACEUTICALS, INC.	-3.75x	-	-	-.--%	2.28B
ARGENX SE	32.76x	8.52x	25.76x	0.06%	55.19B
WUXI APPTEC CO., LTD.	17.19x	5.15x	11.19x	1.75%	45.75B
BIONTECH SE	-17.99x	4.24x	-7.4x	-.--%	22.98B
INSMED INCORPORATED	-36.23x	11.97x	-34.9x	-.--%	20.76B
WUXI BIOLOGICS (CAYMAN) INC.	20.08x	3.91x	10.15x	-.--%	16.26B
GENMAB A/S	21.67x	4.34x	14.36x	-.--%	15.42B
EXELIXIS, INC.	16.41x	4.73x	11.09x	-.--%	13.05B
PHARMAESSENTIA CORPORATION	41.21x	15.94x	46.81x	-.--%	12.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-434.11x	29.51x	-3290.08x	-.--%	12.37B
Average	-34.28x	9.81x	-357.00x	0.18%	21.65B
Weighted average by Cap.	-11.84x	8.44x	-179.96x	0.38%